Brooks O'Neil
Stock Analyst at Lake Street
(0.79)
# 3,750
Out of 4,853 analysts
36
Total ratings
25.71%
Success rate
-18.55%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $6.50 | +207.69% | 2 | Apr 21, 2025 | |
| SRDX Surmodics | Upgrades: Buy | $43 | $30.49 | +41.03% | 4 | Mar 7, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $82.55 | +33.25% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $19.45 | +54.24% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $35.76 | +98.55% | 1 | Jan 24, 2025 | |
| MODV ModivCare | Maintains: Buy | $30 → $10 | $2.31 | +332.90% | 3 | Jan 13, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $20 → $14 | $5.93 | +136.09% | 6 | Jan 8, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $12.72 | +104.40% | 1 | Dec 19, 2024 | |
| LFMD LifeMD | Initiates: Buy | $12 | $12.29 | -2.36% | 1 | Dec 10, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $29.51 | +86.38% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $12.28 | +46.58% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.86 | +74.83% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $75 | $20.18 | +271.66% | 1 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $6.42 | +86.92% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $20.15 | +29.03% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $45 | $5.19 | +767.05% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.84 | +1,214.53% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $27.38 | +365.67% | 1 | Sep 15, 2020 |
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $6.50
Upside: +207.69%
Surmodics
Mar 7, 2025
Upgrades: Buy
Price Target: $43
Current: $30.49
Upside: +41.03%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $82.55
Upside: +33.25%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $19.45
Upside: +54.24%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $35.76
Upside: +98.55%
ModivCare
Jan 13, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $2.31
Upside: +332.90%
AVITA Medical
Jan 8, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $5.93
Upside: +136.09%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $12.72
Upside: +104.40%
LifeMD
Dec 10, 2024
Initiates: Buy
Price Target: $12
Current: $12.29
Upside: -2.36%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $29.51
Upside: +86.38%
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $12.28
Upside: +46.58%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $2.86
Upside: +74.83%
May 22, 2024
Maintains: Buy
Price Target: $60 → $75
Current: $20.18
Upside: +271.66%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $6.42
Upside: +86.92%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $20.15
Upside: +29.03%
Nov 21, 2022
Assumes: Buy
Price Target: $45
Current: $5.19
Upside: +767.05%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.84
Upside: +1,214.53%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $27.38
Upside: +365.67%